Pinch-off syndrome in patients with sickle cell disease receiving erythrocytapheresis

Pediatric Blood and Cancer

Volumn 50, Issue 2, 2008, Pages 354-356

  Nuss, Rachelle ^a,c   Cole, Laura ^a   Le, Tuan ^b   Orsini, Edmund ^b   Harned, Roger ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b CHILDREN S HOSPITAL   (United States)

^c Box B 115 ^*  (United States)

Author keywords

CVAD; Erythrocytapheresis; Sickle cell

Indexed keywords

ARTICLE; CASE REPORT; COMPLICATION; CYTAPHERESIS; DEVICE REMOVAL; ERYTHROCYTAPHERESIS; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; MEDICAL INSTRUMENTATION; PINCH OFF SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; SICKLE CELL ANEMIA; TREATMENT OUTCOME; TUBE; VASCULAR ACCESS;

ANEMIA, SICKLE CELL; BLOOD COMPONENT REMOVAL; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHILD; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; SUBCLAVIAN VEIN;

EID: 37549038259     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21058     Document Type: Article

References (15)

1. Hilliard LM, Williams BF, Lounsbury AE, et al. Erythrocytapheresis limits iron accumulation in chronically transfused sickle cell patients. Am J Hematol 1998;59:28-35.
2. Adams DM, Schultz WH, Ware RE, et al. Erythroctyapheresis can reduce iron overload and prevent the need for chelation therapy in chronically transfused pediatric patients. J Pediatr Hematol Oncol 1996;18:46-50.
3. Singer ST, Quirolo K, Nishi K, et al. Erythrocytapheresis for chronically transfused children with sickle cell disease: An effective method for maintaining a low hemoglobin S level and reducing iron overload. J Clin Apher 1999;14:122-125.
4. Kleinman SH, Hurvitz CG, Goldfiner D. Use of erythrocytapheresis in the treatment of patients with sickle cell anemia. J Clin Apher 1984;2:170-176.
5. Kim HC, Dugan NP, Silber JH, et al. Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease. Blood 1994;83:1136-1142.
6. Kirkham FJ, DeBaun MR. Stroke in children with sickle cell disease. Curr Treat Options Neurol 2004;6:357-375.
7. Thurston GB, Henderson NM, Jeng M. Effects of erythrocytapheresis transfusion on the viscoleasticity of sickle cell blood. Clin Hemorheol Microcirc 2004;3:83-97.
8. Nifong TO, Domen RE. Oxygen saturation and hemoglobin A content in patients with sickle cell disease undergoing erythrocytapherseis. Ther Apher 2002;6:390-393.
9. Fratino G, Mazzola C, Buffa P, et al. Mechanical complications related to indwelling central venous catheter in pediatric hematology/oncology patients. Pediatr Hematol Oncol 2001;18: 317-324.
10. Hinke DH, Zandt-Stastny DA, Goodman LR, et al. Pinch-off syndrome: A complication of implantable subclavian access devices. Radiology 1990;177:353-356.
11. Andris DA, Krzywda EA, Schulte W, et al. Pinch-off syndrome: A rare etiology for central venous catheter occlusion. JPEN 1994; 18:531-533.
12. Mirza B, Vanek VW, Kupensky DT. Pinch-off syndrome: Case report and collective review of the literature. Am Surg 2004;70: 635-644.
13. Fazeny-Dorner B, Wenzel C, Berzlancovich A, et al. Central venous catheter pinch-off and fracture: Recognition, prevention and management. Bone Marrow Transplant 2003;31:927-930.
14. Andris D, Krxywda EA. Catheter pinch-off syndrome: Recognition and management. J IV Nursing 1997;20:233-237.
15. Nace CS, Ingle RJ. Central venous catheter "pinch-off" and fracture: A review of two under-recognized complications. Oncol Nurs Forum 1003;20:1227-1236.